---
title: "BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9 | BBIO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278762678.md"
description: "BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9 | BBIO Stock News"
datetime: "2026-03-11T10:01:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278762678.md)
  - [en](https://longbridge.com/en/news/278762678.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278762678.md)
---

# BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9 | BBIO Stock News

BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9 | BBIO Stock News

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBIO.US](https://longbridge.com/en/quote/BBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [BridgeBio Pharma (NASDAQ:BBIO) Coverage Initiated by Analysts at Royal Bank Of Canada](https://longbridge.com/en/news/282203534.md)
- [Verastem Says Avmapki, Fakzynja Combination Sustains Benefits for 2 Years in Ovarian Cancer](https://longbridge.com/en/news/282339286.md)
- [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md)
- [Revolution Medicines Says Daraxonrasib Shows Improvement In Survival In Late-Stage Pancreatic Cancer Study](https://longbridge.com/en/news/282550417.md)
- [PolyPid To Present New Phase 3 SHIELD II Data On D-PLEX100 At ESCMID 2026](https://longbridge.com/en/news/282665678.md)